Global Bioprocess Technology Market Size and Forecast 2024-2033 | Sartorius AG, Danaher Corporation, Thermo Fisher Scientific Inc., Lonza Group AG, F. Hoffmann-La Roche Ltd.

The Bio-Pharmaceutical Logistics by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Bio-Pharmaceutical Logistics Market:

https://www.thebusinessresearchcompany.com/report/bio-pharmaceutical-logistics-global-market-report

According to The Business Research Company’s Bio-Pharmaceutical Logistics, The bio-pharmaceutical logistics market size has grown rapidly in recent years. It will grow from $131.79 billion in 2023 to $145.69 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%.  The  growth in the historic period can be attributed to rise in clinical trials, globalization of pharmaceutical supply chains, increase in personalized medicine, temperature-sensitive clinical materials, focus on patient-centric logistics, pharmaceutical serialization initiatives..

The bio-pharmaceutical logistics market size is expected to see rapid growth in the next few years. It will grow to $215.69 billion in 2028 at a compound annual growth rate (CAGR) of 10.3%.  The growth in the forecast period can be attributed to gene and cell therapies market growth, sustainable logistics practices, rise in orphan drug development, adoption of autonomous vehicles, demand for biologics and biosimilars, precision medicine logistics.. Major trends in the forecast period include technology integration in logistics, digitalization of supply chains, risk mitigation and contingency planning, strategic partnerships and collaborations, patient-centric distribution models..

The increasing use of biologics is expected to propel the bio-pharmaceutical logistics market going forward. Biologics refers to powerful medication products that are produced from living organisms or contain components of living organisms. It is possible for biological drugs to interact with containers or packaging components due to their sensitivity, thus requiring cold or even cryogenic storage. Biopharmaceutical logistics provides services for handling biopharmaceuticals such as plasma, and temperature-sensitive products that enable access to life-saving healthcare products such as biologics, medicines, and vaccines. For instance, in 2021, according to the Academy of Health Information Professionals, a US-based national association, revenues from biological drugs ($17 billion) in 2021, were twice as high as compared to those from non-biologic drugs ($8 billion) in the USA. Therefore, the increasing use of biologics is driving the bio-pharmaceutical logistics market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=8947&type=smp

The bio-pharmaceutical logistics market covered in this report is segmented –

1) By Type: Cold Chain Logistics, Non-Cold Chain Logistics
2) By Service: Transportation, Warehousing And Distribution, Value Added Services
3) By Retail Format: Specialty Stores, Hyper Markets, Departmental Stores
4) By Application: Ground Shipping, Sea Shipping, Air Shipping
5) By End Users: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, Other End Users

Technological advancement is a key trend gaining popularity in the bio-pharmaceutical logistics market. Major companies operating in the market are advancing toward innovative technologies to sustain their position in the market. For instance, in September 2022, CubeWorks, a US-based company providing breakthrough smart sensing solutions launched CubiSens XT1, a next-generation visibility solution for cold chain logistics. As the first temperature tracker of its kind, the XT1 monitors biopharma products throughout their entire lifecycle to ensure temperature compliance and quality assurance. It contained the world’s smallest temperature tracker as well as ultra-small IoT sensing technology solutions for temperature-sensitive biopharma products. Cold chain logistics challenges today include fragmented temperature monitoring, data aggregation challenges, and incomplete tracking across the supply chain due to outdated temperature data loggers which can be addressed by CubiSens XT1. Powering the CubiSens XT1 is CubeWorks’ patented ultra-low power system-on-chip solution. It reduces the number of components in IoT devices by 10 times, making it highly scalable and cost-effective.

The bio-pharmaceutical logistics market report table of contents includes:

1. Executive Summary

2. Bio-Pharmaceutical Logistics Market Characteristics

3. Bio-Pharmaceutical Logistics Market Trends And Strategies

4. Bio-Pharmaceutical Logistics Market – Macro Economic Scenario

5. Global Bio-Pharmaceutical Logistics Market Size and Growth

 

…

31. Global Bio-Pharmaceutical Logistics Market Competitive Benchmarking

32. Global Bio-Pharmaceutical Logistics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Bio-Pharmaceutical Logistics Market

34. Bio-Pharmaceutical Logistics Market Future Outlook and Potential Analysis

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model